Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study

BACKGROUND: Inhaled corticosteroids (ICS) offer targeted treatment for bronchopulmonary dysplasia (BPD) with minimal systemic effects compared to systemic steroids. However, dosing of ICS in the management of infants at high-risk of developing BPD is not well established. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghuram, Kamini, Dunn, Michael, Jangaard, Krista, Reilly, Maureen, Asztalos, Elizabeth, Kelly, Edmond, Vincer, Michael, Shah, Vibhuti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938808/
https://www.ncbi.nlm.nih.gov/pubmed/29734948
http://dx.doi.org/10.1186/s12887-018-1134-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938808/
https://www.ncbi.nlm.nih.gov/pubmed/29734948
http://dx.doi.org/10.1186/s12887-018-1134-7

Ejemplares similares